Locquet, M., Beaudart, C., Pétermans, J., Reginster, J., & Bruyère, O. (2019). EWGSOP2 Versus EWGSOP1: Impact on the Prevalence of Sarcopenia and Its Major Health Consequences.
Citace podle Chicago (17th ed.)Locquet, Médéa, Charlotte Beaudart, Jean Pétermans, Jean‐Yves Reginster, a Olivier Bruyère. EWGSOP2 Versus EWGSOP1: Impact on the Prevalence of Sarcopenia and Its Major Health Consequences. 2019.
Citace podle MLA (9th ed.)Locquet, Médéa, et al. EWGSOP2 Versus EWGSOP1: Impact on the Prevalence of Sarcopenia and Its Major Health Consequences. 2019.
Upozornění: Tyto citace jsou generovány automaticky. Nemusí být zcela správně podle citačních pravidel..